Literature DB >> 3016550

Synergism between immunoglobulin enhancers and promoters.

J V Garcia, L T Bich-Thuy, J Stafford, C Queen.   

Abstract

Enhancers are DNA sequences that stimulate transcription from eukaryotic promoters. This stimulatory effect can be exerted over large distances and from a position either 5' or 3' of a promoter. Enhancers have been found in the genomes of many viruses, and in some cellular genes such as those encoding immunoglobulin heavy chain and kappa light chain. An important feature of both viral and cellular enhancers is the ability of each enhancer to stimulate transcription from many promoters other than the one with which it is found associated. However, the question of whether cellular enhancers stimulate their 'own' promoter more efficiently than other promoters has apparently not been investigated. We show here that the kappa light-chain enhancer stimulates a kappa promoter about 20-fold more than it stimulates either the simian virus 40 (SV40) early promoter or a metallothionein (MT) promoter, two promoters that are very sensitive to other enhancers. Similarly, the heavy-chain enhancer stimulates a heavy-chain promoter much more than it stimulates the SV40 and MT promoters. This synergism between immunoglobulin enhancers and promoters might be due to the action of a protein that binds specifically to each of the regulatory elements.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3016550     DOI: 10.1038/322383a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  46 in total

1.  The Oct-1 POU domain mediates interactions between Oct-1 and other POU proteins.

Authors:  C P Verrijzer; J A van Oosterhout; P C van der Vliet
Journal:  Mol Cell Biol       Date:  1992-02       Impact factor: 4.272

2.  Identification of an octamer-binding site in the human kappa light-chain enhancer.

Authors:  K Nelms; B Van Ness
Journal:  Mol Cell Biol       Date:  1990-07       Impact factor: 4.272

3.  Transcriptional control of the invariant chain gene involves promoter and enhancer elements common to and distinct from major histocompatibility complex class II genes.

Authors:  L Zhu; P P Jones
Journal:  Mol Cell Biol       Date:  1990-08       Impact factor: 4.272

4.  trans-acting factors interact with a cyclic AMP response element to modulate expression of the human gonadotropin alpha gene.

Authors:  J L Jameson; P J Deutsch; G D Gallagher; R C Jaffe; J F Habener
Journal:  Mol Cell Biol       Date:  1987-09       Impact factor: 4.272

5.  Every enhancer works with every promoter for all the combinations tested: could new regulatory pathways evolve by enhancer shuffling?

Authors:  M Kermekchiev; M Pettersson; P Matthias; W Schaffner
Journal:  Gene Expr       Date:  1991-04

6.  Activation of immunoglobulin control elements in transgenic mice.

Authors:  A E Miller; D L Ennist; K Ozato; H Westphal
Journal:  Immunogenetics       Date:  1992       Impact factor: 2.846

7.  The gap protein knirps mediates both quenching and direct repression in the Drosophila embryo.

Authors:  D N Arnosti; S Gray; S Barolo; J Zhou; M Levine
Journal:  EMBO J       Date:  1996-07-15       Impact factor: 11.598

8.  Paradoxical effect of Simian virus 40 enhancer on the function of mouse DNA polymerase beta gene promoter.

Authors:  M Yamaguchi; Y Obata; A Matsukage
Journal:  Nucleic Acids Res       Date:  1989-05-25       Impact factor: 16.971

9.  Recombination and transcription of the endogenous Ig heavy chain locus is effected by the Ig heavy chain intronic enhancer core region in the absence of the matrix attachment regions.

Authors:  E Sakai; A Bottaro; L Davidson; B P Sleckman; F W Alt
Journal:  Proc Natl Acad Sci U S A       Date:  1999-02-16       Impact factor: 11.205

10.  A humanized antibody that binds to the interleukin 2 receptor.

Authors:  C Queen; W P Schneider; H E Selick; P W Payne; N F Landolfi; J F Duncan; N M Avdalovic; M Levitt; R P Junghans; T A Waldmann
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.